<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34342169</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Combining structural and metabolic markers in a quantitative MRI study of motor neuron diseases.</ArticleTitle><Pagination><StartPage>1774</StartPage><EndPage>1785</EndPage><MedlinePgn>1774-1785</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51418</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To assess the performance of a combination of three quantitative MRI markers (iron deposition, basal neuronal metabolism, and regional atrophy) for differential diagnosis between amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS).</AbstractText><AbstractText Label="METHODS">In total, 33 ALS, 12 PLS, and 28 healthy control (HC) subjects underwent a 3T MRI study including single- and multi-echo sequences for gray matter (GM) volumetry and quantitative susceptibility mapping (QSM) and a pseudo-continuous arterial spin labeling (ASL) sequence for cerebral blood flow (CBF) measurement. Mean values of QSM, CBF, and GM volumes were extracted in the motor cortex, basal ganglia, thalamus, amygdala, and hippocampus. A generalized linear model was applied to the three measures to binary discriminate between groups. The diagnostic performances were evaluated via receiver operating characteristic analyses.</AbstractText><AbstractText Label="RESULTS">A significant discrimination was obtained: between ALS and HCs in the left and right motor cortex, where QSM increases were respectively associated with disability scores and disease duration; between PLS and ALS in the left motor cortex, where PLS patients resulted significantly more atrophic; between ALS and HC in the right motor cortex, where GM volumes were associated with upper motor neuron scores. Significant discrimination between ALS and HC was achieved in subcortical structures only combining all three parameters.</AbstractText><AbstractText Label="INTERPRETATION">While increased QSM values in the motor cortex of ALS patients is a consolidated finding, combining QSM, CBF, and GM volumetry shows higher diagnostic potential for differentiating ALS patients from HC subjects and, in the motor cortex, between ALS and PLS.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canna</LastName><ForeName>Antonietta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trojsi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3790-8018</Identifier><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Nardo</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caiazzo</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedeschi</LastName><ForeName>Gioacchino</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirillo</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esposito</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5099-9786</Identifier><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>3</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34342169</ArticleId><ArticleId IdType="pmc">PMC8419394</ArticleId><ArticleId IdType="doi">10.1002/acn3.51418</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al&#x2010;Chalabi A, Chio A, et&#xa0;al. Amyotrophic lateral sclerosis. Nat Rev Dis Primer 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014;10:661&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, et&#xa0;al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Turner MR, Wuu J. Defining pre&#x2010;symptomatic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener 2019;20:303&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613999</ArticleId><ArticleId IdType="pubmed">30892087</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Shing SLH, et&#xa0;al. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Front Degener 2019;20:133&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabes J, Matthews L, Filippini N, et&#xa0;al. Quantitative FLAIR MRI in amyotrophic lateral sclerosis. Acad Radiol 2017;24:1187&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605225</ArticleId><ArticleId IdType="pubmed">28572001</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve 2007;35:291&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">17212349</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta&#x2010;Cabronero J, Machts J, Schreiber S, et&#xa0;al. Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis. Radiology 2018;289:195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166868</ArticleId><ArticleId IdType="pubmed">30040038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai A, Chen Z, Ward PGD, et&#xa0;al. Serial assessment of iron in the motor cortex in limb&#x2010;onset amyotrophic lateral sclerosis using quantitative susceptibility mapping. Quant Imaging Med Surg 2020;10:1465&#x2013;1476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358415</ArticleId><ArticleId IdType="pubmed">32676365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai A, Egan GF, Talman P, et&#xa0;al. Magnetic resonance iron imaging in amyotrophic lateral sclerosis. J Magn Reson 2021. [Online ahead of print].</Citation><ArticleIdList><ArticleId IdType="pubmed">33586315</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte G, Contarino VE, Casale S, et&#xa0;al. Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex. Eur Radiol 2021;31:5272&#x2013;5280.</Citation><ArticleIdList><ArticleId IdType="pubmed">33399906</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagli M, Donatelli G, Biagi L, et&#xa0;al. Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. NeuroImage Clin 2016;12:965&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5153607</ArticleId><ArticleId IdType="pubmed">27995062</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean KE, Shen B, Askin G, et&#xa0;al. A specific biomarker for amyotrophic lateral sclerosis: quantitative susceptibility mapping. Clin Imaging 2021;75:125&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">33548870</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatelli G, Caldarazzo Ienco E, Costagli M, et&#xa0;al. MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis. NeuroImage Clin 2019;24:101934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6698695</ArticleId><ArticleId IdType="pubmed">31377555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Lee Y&#x2010;J, Park DW, et&#xa0;al. Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls. Neuroradiology 2017;59:1213&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pubmed">29018934</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer AD, Liu T, Gupta A, et&#xa0;al. Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. Am J Roentgenol 2015;204:1086&#x2013;1092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4889122</ArticleId><ArticleId IdType="pubmed">25905946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheelakumari R, Madhusoodanan M, Radhakrishnan A, et&#xa0;al. A potential biomarker in amyotrophic lateral sclerosis: can assessment of brain iron deposition with SWI and corticospinal tract degeneration with DTI Help? Am J Neuroradiol 2016;37:252&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7959949</ArticleId><ArticleId IdType="pubmed">26494694</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidman EK, Schweitzer AD, Niogi SN, et&#xa0;al. Diffusion tensor imaging and quantitative susceptibility mapping as diagnostic tools for motor neuron disorders. Clin Imaging 2019;53:6&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">30286313</ArticleId></ArticleIdList></Reference><Reference><Citation>Rule RR, Schuff N, Miller RG, Weiner MW. Gray matter perfusion correlates with disease severity in ALS. Neurology 2010;74:821&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839193</ArticleId><ArticleId IdType="pubmed">20147656</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D, Hou BO, Xu Y, et&#xa0;al. Brain structural and perfusion signature of amyotrophic lateral sclerosis with varying levels of cognitive deficit. Front Neurol 2018;9:364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976730</ArticleId><ArticleId IdType="pubmed">29881369</ArticleId></ArticleIdList></Reference><Reference><Citation>Welton T, Maller JJ, Lebel RM, et&#xa0;al. Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis. NeuroImage Clin 2019;24:101953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664242</ArticleId><ArticleId IdType="pubmed">31357149</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignjatovi&#x107; A, Stevi&#x107; Z, Lavrni&#x107; S, et&#xa0;al. Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. J Magn Reson Imaging 2013;38:1472&#x2013;1479.</Citation><ArticleIdList><ArticleId IdType="pubmed">23564606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P, et&#xa0;al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 2012;7:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen HH, Johnsen KB, Moos T. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell Mol Life Sci 2014;71:1607&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3983878</ArticleId><ArticleId IdType="pubmed">24218010</ArticleId></ArticleIdList></Reference><Reference><Citation>Contarino VE, Conte G, Morelli C, et&#xa0;al. Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: a fully automatic investigation of the magnetic susceptibility in the precentral cortex. Eur J Radiol 2020;124:108815.</Citation><ArticleIdList><ArticleId IdType="pubmed">31945675</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Hi Shing L, Chipika RH, et&#xa0;al. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. NeuroImage Clin 2019;24:102089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6978214</ArticleId><ArticleId IdType="pubmed">31795059</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et&#xa0;al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Barohn RJ, Corcia P, et&#xa0;al. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry 2020;91:373&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147236</ArticleId><ArticleId IdType="pubmed">32029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et&#xa0;al. The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Cagnin A, Turkheimer FE, et&#xa0;al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)&#x2010;PK11195 positron emission tomography study. Neurobiol Dis 2004;15:601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, et&#xa0;al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Front Degener 2016;17:489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, Trojsi F, et&#xa0;al. Edinburgh Cognitive and Behavioural ALS Screen (ECAS)&#x2010;Italian version: regression based norms and equivalent scores. Neurol Sci 2017;38:1059&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">28332040</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas&#x2010;Garcia R, Scott KM, et&#xa0;al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135:847&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale AM, Fischl B, Sereno MI. Cortical surface&#x2010;based analysis: I. segmentation and surface reconstruction. NeuroImage 1999;9:179&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">9931268</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale AM, Sereno MI. Improved localizadon of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J Cogn Neurosci 1993;5:162&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">23972151</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, Sereno MI, Dale AM. Cortical surface&#x2010;based analysis: II: inflation, flattening, and a surface&#x2010;based coordinate system. NeuroImage 1999;9:195&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">9931269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 2001;20:70&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">11293693</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050&#x2013;11055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27146</ArticleId><ArticleId IdType="pubmed">10984517</ArticleId></ArticleIdList></Reference><Reference><Citation>Salat DH, Buckner RL, Snyder AZ, et&#xa0;al. Thinning of the cerebral cortex in aging. Cereb Cortex 2004;14:721&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">15054051</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe9;gonne F, Dale AM, Busa E, et&#xa0;al. A hybrid approach to the skull stripping problem in MRI. NeuroImage 2004;22:1060&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pubmed">15219578</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsop DC, Detre JA, Golay X, et&#xa0;al. Recommended implementation of arterial spin&#x2010;labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4190138</ArticleId><ArticleId IdType="pubmed">24715426</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Avram AV, Wu B, et&#xa0;al. Integrated Laplacian&#x2010;based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed 2014;27:219&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3947438</ArticleId><ArticleId IdType="pubmed">24357120</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. NeuroImage 2011;55:1645&#x2013;1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3062654</ArticleId><ArticleId IdType="pubmed">21224002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Li W, Guidon A, Liu C. Whole brain susceptibility mapping using compressed sensing. Magn Reson Med 2012;67:137&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3249423</ArticleId><ArticleId IdType="pubmed">21671269</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Wei H, Gong N&#x2010;J, et&#xa0;al. Quantitative susceptibility mapping: contrast mechanisms and clinical applications. Tomography 2015;1:3&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4734903</ArticleId><ArticleId IdType="pubmed">26844301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlund LO, Barkhof F, Fazekas F, et&#xa0;al. A new rating scale for age&#x2010;related white matter changes applicable to MRI and CT. Stroke 2001;32:1318&#x2013;1322.</Citation><ArticleIdList><ArticleId IdType="pubmed">11387493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazekas F, Chawluk JB, Alavi A, et&#xa0;al. MR signal abnormalities at 1.5 T in Alzheimer&#x2019;s dementia and normal aging. Am J Roentgenol 1987;149:351&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">3496763</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et&#xa0;al. Amyotrophic lateral sclerosis &#x2010; frontotemporal spectrum disorder (ALS&#x2010;FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Front Degener 2017;18:153&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Elamin M, Byrne S, et&#xa0;al. Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology 2013;81:2107&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pubmed">24212388</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, Loewe K, Kaufmann J, et&#xa0;al. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology 2015;85:1301&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay L, Worbe Y, Thobois S, et&#xa0;al. Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord 2015;30:1155&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">25772380</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Karavasilis E, Rentzos M, et&#xa0;al. Hippocampal pathology in amyotrophic lateral sclerosis: selective vulnerability of subfields and their associated projections. Neurobiol Aging 2019;84:178&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">31629116</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Di Nardo F, Caiazzo G, et&#xa0;al. Hippocampal connectivity in amyotrophic lateral sclerosis (ALS): more than Papez circuit impairment. Brain Imaging Behav 2020. [Online ahead of print].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8413176</ArticleId><ArticleId IdType="pubmed">33095382</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H&#x2010;J, Verstraete E, Walhout R, et&#xa0;al. Subcortical structures in amyotrophic lateral sclerosis. Neurobiol Aging 2015;36:1075&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">25281019</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Tredici KD, Toledo JB, et&#xa0;al. Stages of pTDP&#x2010;43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013;74:20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika RH, Christidia F, Finegana E, et&#xa0;al. Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis. J Neurol Sci 2020;417:117039.</Citation><ArticleIdList><ArticleId IdType="pubmed">32713609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro PM, Jester C, Olm CA, et&#xa0;al. Perfusion alterations converge with patterns of pathological spread in transactive response DNA&#x2010;binding protein 43 proteinopathies. Neurobiol Aging 2018;68:85&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993674</ArticleId><ArticleId IdType="pubmed">29751289</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, Keute M, Kaufmann J, et&#xa0;al. Longitudinal clinical and neuroanatomical correlates of memory impairment in motor neuron disease. NeuroImage Clin 2021;29:102545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786131</ArticleId><ArticleId IdType="pubmed">33387861</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Galantucci S, Riva N, et&#xa0;al. Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS. Hum Brain Mapp 2014;35:1710&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6869498</ArticleId><ArticleId IdType="pubmed">23633431</ArticleId></ArticleIdList></Reference><Reference><Citation>Canu E, Agosta F, Galantucci S, et&#xa0;al. Extramotor damage is associated with cognition in primary lateral sclerosis patients. PLoS One 2013;8:e82017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857796</ArticleId><ArticleId IdType="pubmed">24349172</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Li Hi Shing S, Siah WF, et&#xa0;al. Evolving diagnostic criteria in primary lateral sclerosis: the clinical and radiological basis of &#x201c;probable PLS&#x201d;. J Neurol Sci 2020;417:117052.</Citation><ArticleIdList><ArticleId IdType="pubmed">32731060</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Wicks P, Brownstein CA, et&#xa0;al. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011;82:853&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">20562391</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MS, Pannek K, Coulthard A, et&#xa0;al. Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis. NeuroImage Clin 2015;7:782&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375643</ArticleId><ArticleId IdType="pubmed">25844330</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa DM, Ceccarelli A, Dicuonzo F, et&#xa0;al. Whole&#x2010;brain and regional brain atrophy in amyotrophic lateral sclerosis. Am J Neuroradiol 2007;28:255&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977419</ArticleId><ArticleId IdType="pubmed">17296989</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespi C, Cerami C, Dodich A, et&#xa0;al. Microstructural white matter correlates of emotion recognition impairment in amyotrophic lateral sclerosis. Cortex 2014;53:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24534360</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri A, Naccarato M, Abrahams S, et&#xa0;al. Right hemisphere dysfunction and emotional processing in ALS: an fMRI study. J Neurol 2010;257:1970&#x2013;1978.</Citation><ArticleIdList><ArticleId IdType="pubmed">20593194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedda A. Disorders of emotional processing in amyotrophic lateral sclerosis. Curr Opin Neurol 2014;27:659&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pubmed">25333604</ArticleId></ArticleIdList></Reference><Reference><Citation>Pringle CE, Hudson AJ, Munoz DG, et&#xa0;al. Primary lateral sclerosis: clinical features. Neurophatology and diagnostic criteria. Brain 1992;115:495&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">1606479</ArticleId></ArticleIdList></Reference><Reference><Citation>Betts MJ, Acosta&#x2010;Cabronero J, Cardenas&#x2010;Blanco A, et&#xa0;al. High&#x2010;resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T. NeuroImage 2016;138:43&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27181761</ArticleId></ArticleIdList></Reference><Reference><Citation>Asllani I, Habeck C, Borogovac A, et&#xa0;al. Separating function from structure in perfusion imaging of the aging brain. Hum Brain Mapp 2009;30:2927&#x2013;2935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2733928</ArticleId><ArticleId IdType="pubmed">19172645</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, Moglia C, Manera U, et&#xa0;al. Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F&#x2010;FDG&#x2010;PET study. J Neurol Neurosurg Psychiatry 2021;92:357&#x2013;363.</Citation></Reference><Reference><Citation>Qin Q, Huang AJ, Hua J, et&#xa0;al. Three&#x2010;dimensional whole&#x2010;brain perfusion quantification using pseudo&#x2010;continuous arterial spin labeling MRI at multiple post&#x2010;labeling delays: accounting for both arterial transit time and impulse response function. NMR Biomed 2014;27:116&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3947417</ArticleId><ArticleId IdType="pubmed">24307572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Hyun J&#x2010;W, Lee J, et&#xa0;al. So you want to image myelin using MRI: an overview and practical guide for myelin water imaging. J Magn Reson Imaging 2021;53:360&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">32009271</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Pradat P&#x2010;F, Querin G, et&#xa0;al. Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front Neurosci 2019;13:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>